Evexia Lifecare Limited (BOM:524444)
India · Delayed Price · Currency is INR 1.320
-0.050 (-3.65%)
At close: Aug 21, 2026
Evexia Lifecare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | - | 865.9 | 562.7 | 695.53 | 755.13 | 1,066 |
Other Revenue | - | - | - | - | 0 | - |
| - | 865.9 | 562.7 | 695.53 | 755.13 | 1,066 | |
Revenue Growth | - | 53.89% | -19.10% | -7.89% | -29.18% | 6.42% |
Cost of Revenue | - | 827.67 | 506.88 | 656.67 | 707.85 | 1,030 |
Gross Profit | - | 38.24 | 55.81 | 38.85 | 47.29 | 36.51 |
Selling, General & Admin | - | 11.1 | 12.72 | 11.45 | 5.82 | 5.86 |
Other Operating Expenses | - | 10.59 | 24.86 | 21.56 | 17.29 | 732.36 |
Operating Expenses | - | 26.41 | 41.74 | 36.94 | 25.18 | 740.63 |
Operating Income | - | 11.83 | 14.07 | 1.91 | 22.11 | -704.13 |
Interest Expense | - | -4.05 | -3.54 | -5.35 | -0.96 | -0.05 |
Interest & Investment Income | - | 0.04 | 7.66 | 12.34 | 0.33 | 0.47 |
Currency Exchange Gain (Loss) | - | - | 1.15 | 0.91 | - | - |
Other Non Operating Income (Expenses) | - | 1.37 | -0.03 | 5.49 | 0.28 | 723.39 |
EBT Excluding Unusual Items | - | 9.19 | 19.31 | 15.3 | 21.76 | 19.69 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.47 |
Pretax Income | - | 9.19 | 19.31 | 15.3 | 21.76 | 19.22 |
Income Tax Expense | - | 5.06 | 5.52 | 8.63 | 13.14 | 6.39 |
Net Income | - | 4.13 | 13.79 | 6.67 | 8.62 | 12.83 |
Net Income to Common | - | 4.13 | 13.79 | 6.67 | 8.62 | 12.83 |
Net Income Growth | - | -70.09% | 106.87% | -22.66% | -32.79% | -63.03% |
Shares Outstanding (Basic) | 2,099 | 1,408 | 708 | 664 | 619 | 619 |
Shares Outstanding (Diluted) | 2,099 | 1,624 | 708 | 664 | 619 | 619 |
Shares Change | - | 129.30% | 6.56% | 7.28% | - | - |
EPS (Basic) | - | 0.00 | 0.02 | 0.01 | 0.01 | 0.02 |
EPS (Diluted) | - | 0.00 | 0.02 | 0.01 | 0.01 | 0.02 |
EPS Growth | - | -86.96% | 94.81% | -28.16% | -30.41% | -64.28% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Free Cash Flow | - | -44.14 | 167.61 | -55.93 | -82.26 | 15.16 |
Free Cash Flow Per Share | - | -0.03 | 0.24 | -0.08 | -0.13 | 0.02 |
Gross Margin | - | 4.42% | 9.92% | 5.59% | 6.26% | 3.42% |
Operating Margin | - | 1.37% | 2.50% | 0.27% | 2.93% | -66.04% |
Profit Margin | - | 0.48% | 2.45% | 0.96% | 1.14% | 1.20% |
Free Cash Flow Margin | - | -5.10% | 29.79% | -8.04% | -10.89% | 1.42% |
EBITDA | - | 16.51 | 18.23 | 5.84 | 24.18 | -701.71 |
EBITDA Margin | - | 1.91% | 3.24% | 0.84% | 3.20% | -65.81% |
D&A For EBITDA | - | 4.68 | 4.16 | 3.93 | 2.08 | 2.42 |
EBIT | - | 11.83 | 14.07 | 1.91 | 22.11 | -704.13 |
EBIT Margin | - | 1.37% | 2.50% | 0.27% | 2.93% | -66.04% |
Effective Tax Rate | - | 55.10% | 28.59% | 56.41% | 60.38% | 33.26% |
Revenue as Reported | - | 867.31 | 571.55 | 714.31 | 755.79 | 1,810 |
Advertising Expenses | - | 0.12 | 0.05 | 0.04 | 0.68 | 0.11 |